Cargando…
Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial
OBJECTIVES: Efficacy of conventional treatment plus the complementary therapy Liu-zi-jue (a mind-body exercise) to treat patients with mild COVID-19. TRIAL DESIGN: The study is a single-center 2 arm, randomized controlled trial with parallel-group design.
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245505/ https://www.ncbi.nlm.nih.gov/pubmed/32446311 http://dx.doi.org/10.1186/s13063-020-04383-2 |
_version_ | 1783537768692973568 |
---|---|
author | Zhang, Shuaipan Lv, Zhizhen Zhu, Qingguang Sun, Wuquan Yao, Fei Fang, Lei Cheng, Yanbin Wu, Zhiwei Fang, Min |
author_facet | Zhang, Shuaipan Lv, Zhizhen Zhu, Qingguang Sun, Wuquan Yao, Fei Fang, Lei Cheng, Yanbin Wu, Zhiwei Fang, Min |
author_sort | Zhang, Shuaipan |
collection | PubMed |
description | OBJECTIVES: Efficacy of conventional treatment plus the complementary therapy Liu-zi-jue (a mind-body exercise) to treat patients with mild COVID-19. TRIAL DESIGN: The study is a single-center 2 arm, randomized controlled trial with parallel-group design. |
format | Online Article Text |
id | pubmed-7245505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72455052020-05-26 Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial Zhang, Shuaipan Lv, Zhizhen Zhu, Qingguang Sun, Wuquan Yao, Fei Fang, Lei Cheng, Yanbin Wu, Zhiwei Fang, Min Trials Letter OBJECTIVES: Efficacy of conventional treatment plus the complementary therapy Liu-zi-jue (a mind-body exercise) to treat patients with mild COVID-19. TRIAL DESIGN: The study is a single-center 2 arm, randomized controlled trial with parallel-group design. BioMed Central 2020-05-23 /pmc/articles/PMC7245505/ /pubmed/32446311 http://dx.doi.org/10.1186/s13063-020-04383-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter Zhang, Shuaipan Lv, Zhizhen Zhu, Qingguang Sun, Wuquan Yao, Fei Fang, Lei Cheng, Yanbin Wu, Zhiwei Fang, Min Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial |
title | Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial |
title_full | Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial |
title_fullStr | Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial |
title_full_unstemmed | Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial |
title_short | Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial |
title_sort | efficacy of liu-zi-jue in patients with 2019 novel coronavirus pneumonia (covid-19): structured summary of a study protocol for a randomized controlled trial |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245505/ https://www.ncbi.nlm.nih.gov/pubmed/32446311 http://dx.doi.org/10.1186/s13063-020-04383-2 |
work_keys_str_mv | AT zhangshuaipan efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT lvzhizhen efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT zhuqingguang efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT sunwuquan efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT yaofei efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT fanglei efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT chengyanbin efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT wuzhiwei efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT fangmin efficacyofliuzijueinpatientswith2019novelcoronaviruspneumoniacovid19structuredsummaryofastudyprotocolforarandomizedcontrolledtrial |